{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:00:53Z","timestamp":1790258453977,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000185","name":"United States Department of Defense | Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["DARPA-5822.e003"],"award-info":[{"award-number":["DARPA-5822.e003"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R37DA045657"],"award-info":[{"award-number":["R37DA045657"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01Actf MH112205Projectf"],"award-info":[{"award-number":["R01Actf MH112205Projectf"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41593-026-02375-0","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:02:29Z","timestamp":1786006949000},"page":"2341-2354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A suite of engineered mice for interrogating psychedelic drug actions"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-7755","authenticated-orcid":false,"given":"Yi-Ting","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel Y.","family":"Deutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin P.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Lu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Dewran","family":"Kocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Llorach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasey R.","family":"Bowyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Sciaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunjie","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Niehaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"DiBerto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-8451","authenticated-orcid":false,"given":"Jessica J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1983-5126","authenticated-orcid":false,"given":"Gr\u00e9gory","family":"Scherrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7260-3439","authenticated-orcid":false,"given":"Melissa A.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2471-0555","authenticated-orcid":false,"given":"Zhuhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-7397","authenticated-orcid":false,"given":"William C.","family":"Wetsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-6520","authenticated-orcid":false,"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2375_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"Berger, M., Gray, J. A. & Roth, B. L. The expanded biology of serotonin. Annu. Rev. Med. 60, 355\u2013366 (2009).","journal-title":"Annu. Rev. Med."},{"key":"2375_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1124\/pr.118.015552","volume":"73","author":"NM Barnes","year":"2021","unstructured":"Barnes, N. M. et al. International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function. Pharmacol. Rev. 73, 310\u2013520 (2021).","journal-title":"Pharmacol. Rev."},{"key":"2375_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.cell.2022.12.020","volume":"186","author":"RH Gumpper","year":"2023","unstructured":"Gumpper, R. H. & Roth, B. L. SnapShot: psychedelics and serotonin receptor signaling. Cell 186, 232 (2023).","journal-title":"Cell"},{"key":"2375_CR4","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","volume":"35","author":"RA Glennon","year":"1984","unstructured":"Glennon, R. A., Titler, M. & McKenney, J. D. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 35, 2505\u20132511 (1984).","journal-title":"Life Sci."},{"key":"2375_CR5","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","volume":"9","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F., Babler, A., Vogel, H. & Hell, D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9, 3897\u20133902 (1998).","journal-title":"Neuroreport"},{"key":"2375_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonzalez-Maeso","year":"2007","unstructured":"Gonzalez-Maeso, J. et al. Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior. Neuron 53, 439\u2013452 (2007).","journal-title":"Neuron"},{"key":"2375_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"MJ Keiser","year":"2009","unstructured":"Keiser, M. J. et al. Predicting new molecular targets for known drugs. Nature 462, 175\u2013181 (2009).","journal-title":"Nature"},{"key":"2375_CR8","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1172\/JCI70678","volume":"123","author":"HY Meltzer","year":"2013","unstructured":"Meltzer, H. Y. & Roth, B. L. Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs. J. Clin. Invest. 123, 4986\u20134991 (2013).","journal-title":"J. Clin. Invest."},{"key":"2375_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","volume":"21","author":"TD McClure-Begley","year":"2022","unstructured":"McClure-Begley, T. D. & Roth, B. L. The promises and perils of psychedelic pharmacology for psychiatry. Nat. Rev. Drug Discov. 21, 463\u2013473 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2375_CR10","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","volume":"182","author":"K Kim","year":"2020","unstructured":"Kim, K. et al. Structure of a hallucinogen activated Gq-coupled 5-HT2A serotonin receptor. Cell 182, 1574\u20131588 (2020).","journal-title":"Cell"},{"key":"2375_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1124\/mol.63.5.961","volume":"63","author":"JA Gray","year":"2003","unstructured":"Gray, J. A., Bhatnagar, A., Gurevich, V. V. & Roth, B. L. The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT2A receptor induces agonist-independent internalization. Mol. Pharmacol. 63, 961\u2013972 (2003).","journal-title":"Mol. Pharmacol."},{"key":"2375_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/272168a0","volume":"272","author":"JE Leysen","year":"1978","unstructured":"Leysen, J. E., Niemegeers, C. J., Tollenaere, J. P. & Laduron, P. M. Serotonergic component of neuroleptic receptors. Nature 272, 168\u2013171 (1978).","journal-title":"Nature"},{"key":"2375_CR13","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1002\/j.1460-2075.1988.tb03308.x","volume":"7","author":"DB Pritchett","year":"1988","unstructured":"Pritchett, D. B. et al. Structure and functional expression of a cloned rat serotonin 5-HT-2 receptor. EMBO J. 7, 4135\u20134140 (1988).","journal-title":"EMBO J."},{"key":"2375_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0169-328X(92)90005-V","volume":"14","author":"K Chen","year":"1992","unstructured":"Chen, K., Yang, W., Grimsby, J. & Shih, J. C. The human 5-HT2 receptor is encoded by a multiple intron\u2013exon gene. Brain Res. Mol. Brain Res. 14, 20\u201326 (1992).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"2375_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0166-4328(96)00093-9","volume":"73","author":"M Toth","year":"1996","unstructured":"Toth, M. Transcriptional regulation of the 5-HT2A receptor. Behav. Brain Res. 73, 183\u2013186 (1996).","journal-title":"Behav. Brain Res."},{"key":"2375_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0026-895X(25)09924-9","volume":"45","author":"MP Johnson","year":"1994","unstructured":"Johnson, M. P., Loncharich, R. J., Baez, M. & Nelson, D. L. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure\u2013activity relationship of certain ergolines and tryptamines. Mol. Pharmacol. 45, 277\u2013286 (1994).","journal-title":"Mol. Pharmacol."},{"key":"2375_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-8993(85)90857-1","volume":"346","author":"A Pazos","year":"1985","unstructured":"Pazos, A., Cortes, R. & Palacios, J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346, 231\u2013249 (1985).","journal-title":"Brain Res."},{"key":"2375_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0006-8993(90)90502-3","volume":"524","author":"G Mengood","year":"1990","unstructured":"Mengood, G., Pompeiano, M., Martinez-Mir, I. & Palacios, J. M. Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Brain Res. 524, 139\u2013143 (1990).","journal-title":"Brain Res."},{"key":"2375_CR19","doi-asserted-by":"crossref","unstructured":"Willins, D., Deutch, A. & Roth, B. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27, 79\u201382 (1997).","DOI":"10.1002\/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A"},{"key":"2375_CR20","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1046\/j.1460-9568.1999.00827.x","volume":"11","author":"JF Lopez-Gimenez","year":"1999","unstructured":"Lopez-Gimenez, J. F., Mengod, G., Palacios, J. M. & Vilaro, M. T. Human striosomes are enriched in 5-HT2A receptors: autoradiographical visualization with [3H]MDL100,907, [125I]\u00b1DOI and [3H]ketanserin. Eur. J. Neurosci. 11, 3761\u20133765 (1999).","journal-title":"Eur. J. Neurosci."},{"key":"2375_CR21","first-page":"36","volume":"4","author":"ET Weber","year":"2010","unstructured":"Weber, E. T. & Andrade, R. Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice. Front. Neurosci. 4, 36 (2010).","journal-title":"Front. Neurosci."},{"key":"2375_CR22","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1073\/pnas.0700293104","volume":"104","author":"BN Armbruster","year":"2007","unstructured":"Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S. & Roth, B. L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl Acad. Sci. USA 104, 5163\u20135168 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2375_CR23","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nn1525","volume":"8","author":"ES Boyden","year":"2005","unstructured":"Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G. & Deisseroth, K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 8, 1263\u20131268 (2005).","journal-title":"Nat. Neurosci."},{"key":"2375_CR24","doi-asserted-by":"crossref","unstructured":"Bubser, M., Backstrom, J. R., Sanders-Bush, E., Roth, B. L. & Deutch, A. Y. Distribution of serotonin 5-HT2A receptors in afferents of the rat striatum. Synapse 39, 297\u2013304 (2001).","DOI":"10.1002\/1098-2396(20010315)39:4<297::AID-SYN1012>3.0.CO;2-Q"},{"key":"2375_CR25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0306-4522(03)00589-X","volume":"122","author":"Z Xia","year":"2003","unstructured":"Xia, Z., Hufeisen, S. J., Gray, J. A. & Roth, B. L. The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro. Neuroscience 122, 907\u2013920 (2003).","journal-title":"Neuroscience"},{"key":"2375_CR26","doi-asserted-by":"publisher","first-page":"21901","DOI":"10.1074\/jbc.M301905200","volume":"278","author":"Z Xia","year":"2003","unstructured":"Xia, Z., Gray, J. A., Compton-Toth, B. A. & Roth, B. L. A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction. J. Biol. Chem. 278, 21901\u201321908 (2003).","journal-title":"J. Biol. Chem."},{"key":"2375_CR27","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1523\/JNEUROSCI.1090-09.2009","volume":"29","author":"AI Abbas","year":"2009","unstructured":"Abbas, A. I. et al. PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. J. Neurosci. 29, 7124\u20137136 (2009).","journal-title":"J. Neurosci."},{"key":"2375_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/PL00005075","volume":"356","author":"JF Lopez-Gimenez","year":"1997","unstructured":"Lopez-Gimenez, J. F., Mengod, G., Palacios, J. M. & Vilaro, M. T. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn Schmiedebergs Arch. Pharmacol. 356, 446\u2013454 (1997).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"2375_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbr.2003.09.028","volume":"146","author":"HB Uylings","year":"2003","unstructured":"Uylings, H. B., Groenewegen, H. J. & Kolb, B. Do rats have a prefrontal cortex? Behav. Brain Res. 146, 3\u201317 (2003).","journal-title":"Behav. Brain Res."},{"key":"2375_CR30","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.1523\/JNEUROSCI.20-23-08846.2000","volume":"20","author":"JL Scruggs","year":"2000","unstructured":"Scruggs, J. L., Patel, S., Bubser, M. & Deutch, A. Y. DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons. J. Neurosci. 20, 8846\u20138852 (2000).","journal-title":"J. Neurosci."},{"key":"2375_CR31","doi-asserted-by":"publisher","first-page":"9691","DOI":"10.1073\/pnas.0603359103","volume":"103","author":"G Scherrer","year":"2006","unstructured":"Scherrer, G. et al. Knockin mice expressing fluorescent \u03b4-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc. Natl Acad. Sci. USA 103, 9691\u20139696 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2375_CR32","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/0024-3205(88)90342-6","volume":"42","author":"NS Buckholtz","year":"1988","unstructured":"Buckholtz, N. S. et al. Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors. Life Sci. 42, 2439\u20132445 (1988).","journal-title":"Life Sci."},{"key":"2375_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1124\/jpet.111.183780","volume":"339","author":"PN Yadav","year":"2011","unstructured":"Yadav, P. N., Kroeze, W. K., Farrell, M. S. & Roth, B. L. Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo. J. Pharmacol. Exp. Ther. 339, 99\u2013105 (2011).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2375_CR34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/00008877-199512000-00010","volume":"6","author":"TE Sipes","year":"1995","unstructured":"Sipes, T. E. & Geyer, M. A. DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2A and not by 5-HT2C receptors. Behav. Pharmacol. 6, 839\u2013842 (1995).","journal-title":"Behav. Pharmacol."},{"key":"2375_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96736-3","volume":"11","author":"RM Rodriguiz","year":"2021","unstructured":"Rodriguiz, R. M. et al. LSD-stimulated behaviors in mice require \u03b2-arrestin 2 but not \u03b2-arrestin 1. Sci. Rep. 11, 17690 (2021).","journal-title":"Sci. Rep."},{"key":"2375_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03611-0","volume":"15","author":"GP Schmitz","year":"2025","unstructured":"Schmitz, G. P. et al. Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation. Transl. Psychiatry 15, 381 (2025).","journal-title":"Transl. Psychiatry"},{"key":"2375_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/brain\/awab406","volume":"145","author":"MK Doss","year":"2022","unstructured":"Doss, M. K. et al. Models of psychedelic drug action: modulation of cortical\u2013subcortical circuits. Brain 145, 441\u2013456 (2022).","journal-title":"Brain"},{"key":"2375_CR38","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/cne.24047","volume":"525","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Organization of the connections between claustrum and cortex in the mouse. J. Comp. Neurol. 525, 1317\u20131346 (2017).","journal-title":"J. Comp. Neurol."},{"key":"2375_CR39","doi-asserted-by":"crossref","unstructured":"Jain, M. K. et al. The polypharmacology of psychedelics reveals multiple targets for potential therapeutics. Neuron 113, 3129\u20133142 (2025).","DOI":"10.1016\/j.neuron.2025.06.012"},{"key":"2375_CR40","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1523\/JNEUROSCI.4388-06.2007","volume":"27","author":"M Fukui","year":"2007","unstructured":"Fukui, M. et al. Vmat2 heterozygous mutant mice display a depressive-like phenotype. J. Neurosci. 27, 10520\u201310529 (2007).","journal-title":"J. Neurosci."},{"key":"2375_CR41","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1073\/pnas.1520244113","volume":"113","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Proc. Natl Acad. Sci. USA 113, 2868\u20132873 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2375_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bbrc.2007.10.128","volume":"365","author":"P Huang","year":"2008","unstructured":"Huang, P. et al. Brain region-specific N-glycosylation and lipid rafts association of the rat \u03bc-opioid receptor. Biochem. Biophys. Res. Commun. 365, 82\u201388 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2375_CR43","doi-asserted-by":"publisher","first-page":"10392","DOI":"10.1523\/JNEUROSCI.0603-16.2016","volume":"36","author":"XF Wang","year":"2016","unstructured":"Wang, X. F. et al. T394A mutation at the \u03bc-opioid receptor blocks opioid tolerance and increases vulnerability to heroin self-administration in mice. J. Neurosci. 36, 10392\u201310403 (2016).","journal-title":"J. Neurosci."},{"key":"2375_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/10520290410001671344","volume":"79","author":"MM Lim","year":"2004","unstructured":"Lim, M. M., Hammock, E. A. & Young, L. J. A method for acetylcholinesterase staining of brain sections previously processed for receptor autoradiography. Biotech. Histochem. 79, 11\u201316 (2004).","journal-title":"Biotech. Histochem."},{"key":"2375_CR45","doi-asserted-by":"crossref","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the $${2}^{-\\varDelta \\varDelta {C}_{{\\rm{t}}}}$$ method. Methods 25, 402\u2013408 (2001).","DOI":"10.1006\/meth.2001.1262"},{"key":"2375_CR46","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nn.2529","volume":"135","author":"AC Magalhaes","year":"2010","unstructured":"Magalhaes, A. C. et al. CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nat. Neurosci. 135, 622\u2013629 (2010).","journal-title":"Nat. Neurosci."},{"key":"2375_CR47","doi-asserted-by":"publisher","first-page":"1233743","DOI":"10.3389\/fmolb.2023.1233743","volume":"10","author":"VM Pogorelov","year":"2023","unstructured":"Pogorelov, V. M., Rodriguiz, R. M., Roth, B. L. & Wetsel, W. C. The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice. Front. Mol. Biosci. 10, 1233743 (2023).","journal-title":"Front. Mol. Biosci."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02375-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02375-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02375-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:18:48Z","timestamp":1790255928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02375-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1038\/s41593-026-02375-0","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.L.R. is an advisory board member or co-founder of XyloBio, ImprintBio and Epiodyne. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}